Alexandre de la Taille Selected Research

Heart Failure

1/2022

Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandre de la Taille Research Topics

Disease

78	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 08/2002
51	Neoplasms (Cancer) 07/2022 - 05/2003
9	Margins of Excision 04/2024 - 09/2002
9	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2018 - 11/2006
8	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 02/2009
7	Carcinoma (Carcinomatosis) 07/2022 - 06/2004
5	Neoplasm Metastasis (Metastasis) 03/2024 - 10/2007
5	Lower Urinary Tract Symptoms 08/2023 - 03/2015
5	Hemorrhage 12/2011 - 06/2003
4	Non-Muscle Invasive Bladder Neoplasms 03/2024 - 01/2017
4	Erectile Dysfunction 12/2017 - 09/2005
4	Inflammation (Inflammations) 12/2015 - 12/2008
4	Urinary Bladder Neoplasms (Bladder Cancer) 08/2015 - 06/2010
3	Prostatic Intraepithelial Neoplasia 01/2014 - 03/2009
3	Urinary Retention 12/2011 - 06/2003
3	Disease Progression 06/2011 - 05/2003
3	Kidney Neoplasms (Kidney Cancer) 01/2011 - 10/2007
2	Infections 02/2023 - 02/2014
2	COVID-19 02/2023 - 01/2021
2	Nocturia 01/2021 - 09/2006
2	Lymphatic Metastasis 01/2020 - 01/2014
2	Pathologic Constriction (Stenosis) 11/2019 - 08/2012
2	Stress Urinary Incontinence 01/2016 - 01/2015
2	Urinary Incontinence 01/2016 - 01/2015
2	Extranodal Extension 04/2013 - 02/2010
2	Prostatitis 07/2011 - 06/2003
2	Urinoma 12/2008 - 04/2006
2	Cysts 12/2008 - 04/2006
2	Abscess 04/2006 - 09/2003
2	Fistula 04/2006 - 08/2003
1	Massive Hepatic Necrosis 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Liver Failure 01/2022
1	Heart Failure 01/2022
1	Digestive System Diseases 01/2022
1	Hypoxia (Hypoxemia) 09/2020
1	Tuberous Sclerosis (Bourneville's Disease) 04/2020
1	Angiomyolipoma 04/2020

Drug/Important Bio-Agent (IBA)

28	Prostate-Specific Antigen (Semenogelase)IBA 03/2024 - 06/2003
16	AndrogensIBA 02/2023 - 07/2006
16	Biomarkers (Surrogate Marker)IBA 04/2022 - 03/2007
8	AntigensIBA 01/2020 - 02/2010
7	Hormones (Hormone)IBA 01/2021 - 05/2003
6	Proteins (Proteins, Gene)FDA Link 12/2015 - 05/2003
4	Messenger RNA (mRNA)IBA 12/2015 - 04/2009
4	Protein Isoforms (Isoforms)IBA 07/2015 - 06/2013
3	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2009
3	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 09/2005
2	Dutasteride (Avodart)FDA Link 08/2023 - 05/2013
2	Androgen Receptors (Androgen Receptor)IBA 02/2023 - 07/2013
2	Sunitinib (Sutent)FDA Link 01/2022 - 11/2016
2	EnzymesIBA 09/2020 - 06/2010
2	MTOR InhibitorsIBA 04/2020 - 01/2011
2	Triptorelin Pamoate (Trelstar)FDA Link 01/2017 - 10/2014
2	Estrogens (Estrogen)FDA Link 08/2015 - 03/2008
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2013 - 11/2005
2	Testosterone (Sustanon)FDA Link 04/2013 - 05/2011
2	Docetaxel (Taxotere)FDA Link 11/2010 - 09/2004
2	Dihydrotachysterol (AT 10)IBA 12/2009 - 02/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2008 - 10/2007
2	Finasteride (Propecia)FDA LinkGeneric 11/2005 - 06/2005
1	erdafitinibIBA 03/2024
1	Tamsulosin (Flomax)FDA LinkGeneric 08/2023
1	apalutamideIBA 02/2023
1	Neuropilin-1IBA 01/2023
1	NucleolinIBA 04/2022
1	NivolumabIBA 01/2022
1	ParaffinIBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	IpilimumabIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Circular RNAIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	5-alpha Reductase InhibitorsIBA 04/2021
1	Carbonic Anhydrase IXIBA 09/2020
1	Hypoxia-Inducible Factor 1IBA 09/2020
1	trans-sodium crocetinate (crocetin)IBA 04/2020

Therapy/Procedure

47	Prostatectomy (Retropubic Prostatectomy) 01/2020 - 08/2002
26	Therapeutics 03/2024 - 04/2002
10	Nephrectomy 01/2017 - 09/2003
6	Cystectomy 12/2022 - 10/2011
5	Transurethral Resection of Prostate (TURP) 12/2011 - 11/2006
4	Drug Therapy (Chemotherapy) 01/2021 - 04/2010
4	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 04/2006
4	Castration 07/2013 - 04/2010
3	Radiotherapy 01/2019 - 06/2004
2	Length of Stay 01/2018 - 12/2011
2	Injections 12/2017 - 08/2014
2	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2017 - 01/2016
2	Suburethral Slings (Tension-Free Vaginal Tape) 01/2016 - 01/2015
2	Adjuvant Chemotherapy 08/2015 - 04/2005
2	Nephroureterectomy 01/2012 - 04/2006
2	Stents 12/2008 - 11/2006
2	Adrenalectomy 12/2008 - 04/2006
2	Colostomy 04/2006 - 08/2003
1	Warm Ischemia 04/2024
1	Urinary Diversion (Ileal Conduit) 07/2022
1	Neoadjuvant Therapy 07/2022